- Home
- IRIX vs CRIS Comparison
IRIX vs CRIS Comparison
Compare IRIX & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IRIX | CRIS |
|---|---|---|
| Founded | 1989 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.2M | 20.6M |
| IPO Year | 1996 | 2000 |
Fundamental Metrics
Financial Performance| Metric | IRIX | CRIS |
|---|---|---|
| Price | $1.03 | $0.52 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $17.00 |
| AVG Volume (30 Days) | 49.7K | ★ 212.0K |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 51.85 | ★ 91.57 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $41,593,000.00 | $9,898,000.00 |
| Revenue This Year | $3.07 | $27.10 |
| Revenue Next Year | $6.66 | $67.74 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 31.50 |
| 52 Week Low | $0.87 | $0.46 |
| 52 Week High | $1.65 | $3.13 |
Technical Indicators
Market Signals| Indicator | IRIX | CRIS |
|---|---|---|
| Relative Strength Index (RSI) | 46.89 | 43.65 |
| Support Level | $1.01 | $0.48 |
| Resistance Level | $1.18 | $0.63 |
| Average True Range (ATR) | 0.03 | 0.04 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 55.56 | 43.37 |
Price Performance
Historical ComparisonAbout IRIX IRIDEX Corporation
IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.